Dishman Carbogen Amcis Quarterly Results

Latest Quarter Net Profit
₹-67 Cr
QSept 2026
Quarterly Results

Dishman Carbogen Amcis quarterly results. In Sept 2026, Dishman Carbogen Amcis (DCAL) reported revenue ₹511 Cr and net profit ₹-67 Cr — revenue -22.7% YoY. For annual financials, live price and key ratios, visit DCAL share price screener.

DCAL Quarterly Results — Revenue, Profit & EPS Highlights

Dishman Carbogen Amcis latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore DCAL share price data to track price trends across different timeframes.

  • Revenue of ₹511 Cr in Sept 2026 (-41.1% vs Mar 2026, -22.7% vs Sept 2025)
  • Net Profit of ₹-67 Cr in Sept 2026 (-404.5% vs Mar 2026, -203.1% vs Sept 2025)
  • EBITDA of ₹50 Cr in Sept 2026 (-71.9% vs Mar 2026)
  • Operating Margin of 9.0% in Sept 2026 (-10.0pp vs Mar 2026)
  • Earnings Per Share of ₹-4.26 in Sept 2026 (-406.5% vs Mar 2026)

Dishman Carbogen Amcis Quarterly Results — Revenue, EBITDA, Net Profit & EPS

DCAL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 511 868 696 661 724 -41.1% -22.7%
Net Profit (₹ Cr) -67 22 -58 65 43 - -
EBITDA (₹ Cr) 50 178 77 157 149 - -
EPS (₹) -4.26 1.39 -3.69 4.16 2.75 - -
Operating Margin (%) 9.0% 19.0% 9.0% 23.0% 20.0% - -

DCAL Share Price Trend — 1-Year Movement Across Quarterly Results

Dishman Carbogen Amcis 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View DCAL yearly price range for the annual high/low range and current price position.

Profitability Ratios

Profit Margin -13.1%
EBITDA Margin 9.8%
Operating Margin 9.0%
ROE (Annual) -4.0%

Balance Sheet Highlights

Total Assets ₹11,923 Cr
Total Equity ₹6,677 Cr
Current Assets ₹ Cr
Current Liabilities ₹2,929 Cr

Cash Flow Analysis

Operating Cash Flow ₹492 Cr
Investing Cash Flow ₹-245 Cr
Financing Cash Flow ₹201 Cr
Net Cash Flow ₹447 Cr

Current Market Data

Current Price ₹118.53
Exchange NSE
Last Updated Nov 19, 2026

DCAL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Dishman Carbogen Amcis latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores